A detailed history of Swiss National Bank transactions in Castle Biosciences Inc stock. As of the latest transaction made, Swiss National Bank holds 51,300 shares of CSTL stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,300
Previous 51,300 -0.0%
Holding current value
$1.51 Million
Previous $1.12 Million 31.09%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$18.84 - $24.94 $20,724 - $27,434
1,100 Added 2.19%
51,300 $1.12 Million
Q4 2023

Feb 06, 2024

SELL
$12.19 - $22.43 $60,950 - $112,150
-5,000 Reduced 9.06%
50,200 $1.08 Million
Q2 2023

Aug 09, 2023

BUY
$11.66 - $26.0 $79,288 - $176,800
6,800 Added 14.05%
55,200 $757,000
Q1 2023

May 10, 2023

SELL
$19.47 - $28.49 $107,085 - $156,695
-5,500 Reduced 10.2%
48,400 $1.1 Million
Q4 2022

Feb 08, 2023

BUY
$18.08 - $30.0 $18,080 - $30,000
1,000 Added 1.89%
53,900 $1.27 Million
Q3 2022

Nov 09, 2022

BUY
$22.51 - $34.32 $47,271 - $72,072
2,100 Added 4.13%
52,900 $1.38 Million
Q2 2022

Aug 09, 2022

BUY
$16.0 - $45.99 $46,400 - $133,371
2,900 Added 6.05%
50,800 $1.12 Million
Q1 2022

May 09, 2022

BUY
$33.17 - $46.98 $119,412 - $169,128
3,600 Added 8.13%
47,900 $2.15 Million
Q3 2021

Nov 08, 2021

BUY
$60.13 - $77.6 $36,078 - $46,560
600 Added 1.37%
44,300 $2.95 Million
Q2 2021

Aug 06, 2021

BUY
$50.07 - $76.78 $115,161 - $176,594
2,300 Added 5.56%
43,700 $3.21 Million
Q1 2021

May 07, 2021

BUY
$58.92 - $97.33 $29,460 - $48,665
500 Added 1.22%
41,400 $2.83 Million
Q4 2020

Feb 05, 2021

BUY
$43.6 - $73.05 $645,280 - $1.08 Million
14,800 Added 56.7%
40,900 $2.75 Million
Q3 2020

Nov 09, 2020

BUY
$38.47 - $52.03 $19,235 - $26,015
500 Added 1.95%
26,100 $1.34 Million
Q2 2020

Aug 05, 2020

BUY
$27.28 - $43.01 $698,368 - $1.1 Million
25,600 New
25,600 $965,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $776M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.